Arab Journal of Gastroenterology
Volume 10, Issue 4, Supplement , Pages S32-S34 , April 2010

Non-invasive systems for staging compensated cirrhosis

References 

  1. Regev A, et al. Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection. Am J Gastroenterol. 2002;97:2614–2618
  2. Bedossa P, et al. Sampling variability of liver fibrosis in chronic hepatitis C. Hepatology. 2003;38:1449–1457
  3. Cadranel JF, et al. Practices of liver biopsy in France: Results of a prospective nationwide survey. Hepatology. 2000;32:477–481
  4. Standish RA, et al. An appraisal of the histopathological assessment of liver fibrosis. Gut. 2006;55:569–578
  5. Samonakis DN, et al. Hepatic venous pressure gradient to assess fibrosis and its progression after liver transplantation for HCV cirrhosis. Liver Transpl. 2007;13:1305–1311
  6. Burroughs AK, et al. Assessment of therapeutic benefit of antiviral therapy in chronic hepatitis C: is hepatic venous pressure gradient a better end point?. Gut. 2005;50:425–427
  7. Rincon D, et al. Antiviral therapy decreases hepatic venous pressure gradient in patients with chronic hepatitis C and advanced fibrosis. Am J Gastroenterol. 2006;101:2269–2274
  8. Senzolo M, et al. The transjugular route: the key hole to the liver world. Dig Dis Sci. 2006;39:105–116
  9. Carrion JA, et al. Efficacy of antiviral therapy on hepatitis C recurrence after liver transplantation: a randomized controlled study. Gastroenterology. 2007;132:1746–1756
  10. Forns X, et al. Identification of chronic hepatitis C patients without hepatic fibrosis by a simple predictive model. Hepatology. 2002;36:986–992
  11. Wai CT, et al. A simple non-invasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology. 2003;38:518–526
  12. Imbert-Bismut F, et al. Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective study. Lancet. 2001;357:1069–1075
  13. Koda M, et al. FibroIndex, a practical index for predicting significant fibrosis in patients with chronic hepatitis C. Hepatology. 2007;45:297–306
  14. Testa R, et al. Non-invasive ratio indexes to evaluate fibrosis staging in chronic hepatitis C: role of platelet count/spleen diameter ratio index. J Int Med. 2006;260:142–150
  15. Sud A, et al. Improved prediction of fibrosis in chronic hepatitis C using measures of insulin resistance in a probability index. Hepatology. 2004;39:1239–1247
  16. Sterling RK, et al. Development of a simple non-invasive index to predict significant fibrosis in patients with chronic hepatitis C. Hepatology. 2006;43:1317–1325
  17. Bonacini M, et al. Utility of a discriminant score for diagnosing advanced fibrosis or cirrhosis in patients with chronic hepatitis C infection. Am J Gastroenterol. 1997;92:1302–1314
  18. Pohl A, et al. Serum aminotransferase levels and platelet counts as predictors of degree of fibrosis in chronic hepatitis C virus infection. Am J Gastroenterol. 2001;96:3142–3146
  19. Sheth SG, et al. AST/ALT ratio predicts cirrhosis in patients with chronic hepatitis C virus infection. Am J Gastroenterol. 1998;93:44–48
  20. Park GJH, et al. Aspartate aminotransferase, alanine aminotransferase ratio in chronic hepatitis C infection: is it a useful predictor of cirrhosis?. J Gastroenterol Hepatol. 2000;15:386–390
  21. Poynard T, Bedossa P. Age and platelet count: a simple index for predicting the presence of histological lesions in patients with antibodies to hepatitis C virus. METAVIR and CLINIVIR Cooperative Study Groups. J Viral Hepat. 1997;4:199–208
  22. Leroy V, et al. Circulating matrix metalloproteinases 1, 2, 9 and their inhibitors TIMP-1 and TIMP-2 as serum markers of liver fibrosis in patients with chronic hepatitis C: comparison with PIIINP and hyaluronic acid. Am J Gastroenterol. 2004;99:271–279
  23. Rosenberg WM, et al. Serum markers detect the presence of liver fibrosis: a cohort study. Gastroenterology. 2004;127:1704–1713
  24. Kellher TB, et al. Prediction of hepatic fibrosis in HIV/HCV co-infected patients using serum fibrosis markers: the SHASTA index. J Hepatol. 2005;43:78–84
  25. Calès P, et al. A novel panel of blood markers to assess the degree of liver fibrosis. Hepatology. 2005;42:1373–1381
  26. Adams LA, et al. Hepascore: an accurate validated predictor of liver fibrosis in chronic hepatitis C infection. Clin Chem. 2005;51:1867–1873
  27. Patel K, et al. Evaluation of a panel of non-invasive serum markers to differentiate mild from moderate-to-advanced liver fibrosis in chronic hepatitis C patients. J Hepatol. 2004;41:935–942
  28. Parkes J, et al. Performance of serum marker panels for liver fibrosis in chronic hepatitis C. J Hepatol. 2006;44:462–474
  29. Afdhal NH, Curry M. Technology evaluation: a critical step in the clinical utilization of novel diagnostic tests for liver fibrosis. J Hepatol. 2007;46:543–545
  30. Sebastiani G, et al. Stepwise combination of algorithms of non-invasive markers to diagnose significant fibrosis in chronic hepatitis C. J Hepatol. 2004;44:686–693
  31. Sebastiani G, et al. Sequential algorithms combining non-invasive markers and biopsy for the assessment of liver fibrosis in chronic hepatitis B. World J Gastroenterol. 2007;13:525–531
  32. Leroy V, et al. Prospective comparison of six non-invasive scores for the diagnosis of liver fibrosis in chronic hepatitis C. J Hepatol. 2007;46:775–782
  33. Lackner C, et al. Comparison and validation of simple non-invasive tests for prediction of fibrosis in chronic hepatitis C. Hepatology. 2005;41:1376–1382
  34. Lackner C, et al. Non-invasive diagnosis of cirrhosis in chronic hepatitis C based on standard laboratory tests. Hepatology. 2006;42:378–379
  35. Sandrin L, et al. Shear elasticity probe for soft tissues with 1-D transient elastography. IEEE Trans Ultrason Ferroelectr Freq Control. 2002;49:436–446
  36. Castera L, et al. Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C. Gastroenterology. 2005;128:343–350
  37. Carrion JA, et al. Transient elastography for diagnosis of advanced fibrosis and portal hypertension in patients with hepatitis C recurrence after liver transplantation. Liver Transpl. 2006;12:1791–1798
  38. Foucher J, et al. Diagnosis of cirrhosis by transient elastography (FibroScan): a prospective study. Gut. 2006;55:403–408
  39. Gomez-Dominguez E, et al. Transient elastography: a valid alternative to biopsy in patients with chronic liver disease. Aliment Pharmacol Ther. 2006;24:513–518
  40. Ganne-Carrie N, et al. Accuracy of liver stiffness measurement for the diagnosis of cirrhosis in patients with chronic liver diseases. Hepatology. 2006;44:1511–1517
  41. de Ledinghen V, et al. Diagnosis of hepatic fibrosis and cirrhosis by transient elastography in HIV/hepatitis C virus co-infected patients. J Acquir Immune Defic Syndr. 2006;41:175–179
  42. Kim KM, et al. Diagnosis of hepatic steatosis and fibrosis by transient elastography in asymptomatic healthy individuals: a prospective study of living related potential liver donors. J Gastroenterol. 2007;42:382–388
  43. Yoneda M, et al. Transient elastography in patients with nonalcoholic fatty liver disease (NAFLD). Gut. 2007;56:1330–1331
  44. Ziol M, et al. Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with chronic hepatitis C. Hepatology. 2005;41:48–54
  45. Fraquelli M, et al. Reproducibility of transient elastography in the evaluation of liver fibrosis in patients with chronic liver disease. Gut. 2007;56:968–973
  46. Corpechot C, et al. Assessment of biliary fibrosis by transient elastography in patients with PBC and PSC. Hepatology. 2006;43:1118–1124
  47. Coco B, et al. Transient elastography: a new surrogate marker of liver fibrosis influenced by major changes of transaminases. J Viral Hepat. 2007;14:360–369
  48. Arena U, Vizzutti F, Abraldes JG, Corti G, Stasic C, Moscarella S, et al. Acute viral hepatitis increases liver stiffness values measured by transient elastography. Hepatology. 2008;57:1288–1293
  49. Vizzutti F, et al. Liver stiffness measurement predicts severe portal hypertension in patients with HCV-related cirrhosis. Hepatology. 2007;45:1290–1297
  50. Foucher J, et al. Diagnosis of cirrhosis by transient elastography (Fibroscan): a prospective study. Gut. 2006;55:403–408
  51. Kazemi F, et al. Liver stiffness measurements selects patients with cirrhosis at risk of bearing large esophageal varices. J Hepatol. 2006;45:230–235

PII: S1687-1979(09)00299-8

doi: 10.1016/j.ajg.2009.12.002

Arab Journal of Gastroenterology
Volume 10, Issue 4, Supplement , Pages S32-S34 , April 2010

Article Tools

* Image Usage & Resolution